View in EDS HTML Full Text PDF Full Text

Cost-Effectiveness of Nirsevimab and Clesrovimab in Preventing Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Modeling Study.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness of Nirsevimab and Clesrovimab in Preventing Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Modeling Study.
Authors: Yarnoff B; Evidera Inc., Wilmington, NC, USA. benjamin.yarnoff@thermofisher.com., Beuvelet M; Sanofi, Lyon, France., Soudani S; Sanofi, Lyon, France., Neary MP; Sanofi, Morristown, NJ, USA., Hodges EN; Sanofi, Morristown, NJ, USA., Chit A; Sanofi, Morristown, NJ, USA.; Lesie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada., Tribaldos M; Sanofi, Morristown, NJ, USA., Gabriel V; Sanofi, Morristown, NJ, USA., Musci R; Evidera Inc., Wilmington, NC, USA., Geurtsen J; Sanofi, Amsterdam, The Netherlands., Krilov LR; Pediatric Infectious Disease Consultant, Woodbury, NY, USA.
Source: Infectious diseases and therapy [Infect Dis Ther] 2026 Apr; Vol. 15 (4), pp. 1047-1073. Date of Electronic Publication: 2026 Feb 26.
Publication Type: Journal Article
Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41746506
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-Effectiveness of Nirsevimab and Clesrovimab in Preventing Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Modeling Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yarnoff+B%22">Yarnoff B</searchLink>; Evidera Inc., Wilmington, NC, USA. benjamin.yarnoff@thermofisher.com.<br /><searchLink fieldCode="AU" term="%22Beuvelet+M%22">Beuvelet M</searchLink>; Sanofi, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Soudani+S%22">Soudani S</searchLink>; Sanofi, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Neary+MP%22">Neary MP</searchLink>; Sanofi, Morristown, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Hodges+EN%22">Hodges EN</searchLink>; Sanofi, Morristown, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Chit+A%22">Chit A</searchLink>; Sanofi, Morristown, NJ, USA.; Lesie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Tribaldos+M%22">Tribaldos M</searchLink>; Sanofi, Morristown, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Gabriel+V%22">Gabriel V</searchLink>; Sanofi, Morristown, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Musci+R%22">Musci R</searchLink>; Evidera Inc., Wilmington, NC, USA.<br /><searchLink fieldCode="AU" term="%22Geurtsen+J%22">Geurtsen J</searchLink>; Sanofi, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Krilov+LR%22">Krilov LR</searchLink>; Pediatric Infectious Disease Consultant, Woodbury, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101634499%22">Infectious diseases and therapy</searchLink> [Infect Dis Ther] 2026 Apr; Vol. 15 (4), pp. 1047-1073. <i>Date of Electronic Publication: </i>2026 Feb 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%22">Adis </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101634499 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8229 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221936382%22">21936382 </searchLink><i>NLM ISO Abbreviation: </i>Infect Dis Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41746506
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40121-026-01311-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1047
    Titles:
      – TitleFull: Cost-Effectiveness of Nirsevimab and Clesrovimab in Preventing Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Modeling Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yarnoff B
      – PersonEntity:
          Name:
            NameFull: Beuvelet M
      – PersonEntity:
          Name:
            NameFull: Soudani S
      – PersonEntity:
          Name:
            NameFull: Neary MP
      – PersonEntity:
          Name:
            NameFull: Hodges EN
      – PersonEntity:
          Name:
            NameFull: Chit A
      – PersonEntity:
          Name:
            NameFull: Tribaldos M
      – PersonEntity:
          Name:
            NameFull: Gabriel V
      – PersonEntity:
          Name:
            NameFull: Musci R
      – PersonEntity:
          Name:
            NameFull: Geurtsen J
      – PersonEntity:
          Name:
            NameFull: Krilov LR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2193-8229
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Infectious diseases and therapy
              Type: main
ResultId 1